Cybin Inc (CYBN)

$0.3599

+0.01

(+1.41%)

Market is closed - opens 7 PM, 23 May 2024

Insights on Cybin Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 58.5% return, outperforming this stock by 31.8%

Performance

  • $0.34
    $0.36
    $0.36
    downward going graph

    5.0%

    Downside

    Day's Volatility :5.0%

    Upside

    0.0%

    downward going graph
  • $0.21
    $0.74
    $0.36
    downward going graph

    41.67%

    Downside

    52 Weeks Volatility :71.54%

    Upside

    51.22%

    downward going graph

Returns

PeriodCybin IncIndex (Russel 2000)
3 Months
-10.76%
0.0%
6 Months
-22.8%
0.0%
1 Year
26.75%
0.0%
3 Years
-87.14%
-20.1%

Highlights

Market Capitalization
265.9M
Book Value
$0.3
Earnings Per Share (EPS)
-0.22
Wall Street Target Price
7.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-44.21%
Return On Equity TTM
-79.36%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
-311.0K
EBITDA
-67.1M
Diluted Eps TTM
-0.22
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.26
EPS Estimate Next Year
-0.15
EPS Estimate Current Quarter
-0.04
EPS Estimate Next Quarter
-0.04

Analyst Recommendation

Buy
    87%Buy
    12%Hold
    0
    0%Sell
Based on 8 Wall street analysts offering stock ratings for Cybin Inc(by analysts ranked 0 to 5 stars)
Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
8
8
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 1844.98%

Current $0.36
Target $7.00

Technicals Summary

Sell

Neutral

Buy

Cybin Inc is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cybin Inc
Cybin Inc
-1.53%
-22.8%
26.75%
-87.14%
-87.14%
Moderna, Inc.
Moderna, Inc.
37.56%
83.82%
13.37%
-12.47%
553.14%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
10.42%
24.29%
32.26%
98.6%
210.52%
Novo Nordisk A/s
Novo Nordisk A/s
7.9%
30.89%
58.53%
230.87%
458.51%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
10.52%
25.13%
30.01%
109.26%
156.43%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cybin Inc
Cybin Inc
NA
NA
NA
-0.26
-0.79
-0.44
NA
0.3
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-6.46
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
29.16
29.16
1.46
44.2
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.83
45.83
2.36
3.5
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
28.9
28.9
0.53
17.11
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cybin Inc
Cybin Inc
Buy
$265.9M
-87.14%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$54.0B
553.14%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$108.8B
210.52%
29.16
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$592.1B
458.51%
45.83
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$115.1B
156.43%
28.9
39.46%

Company Information

Organization
Cybin Inc
Employees
50
CEO
Mr. Eric So L.L.B.
Industry
Miscellaneous

FAQs